logo-loader

Evgen Pharma PLC

Receive alerts
Market:
AIM
Market Cap:
£8.27 m
Price
6.24 GBX
Change
-4.06%
52 weeks high
33.00
52 weeks low
4.50

In brief

Evgen Pharma PLC, a clinical stage drug development company focused on the treatment of cancer and neurological conditions.

Latest

RNS

Holding(s) in Company

1 week, 3 days ago
RNS

Holding(s) in Company

2 weeks, 5 days ago
RNS

Half-year Report

on 17/12/19
RNS

Notice of Results

on 4/12/19